Poly(histidine-arginine)6 modified chitosan nanoparticle for siRNA delivery in melanoma therapy
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: SUN, Ping (Institute of Materia Medica, Department of Pharmaceutics, Beijing, China)
- Co-author(s): Ping Sun: Department of Pharmaceutics, Institute of Materia Medica, Beijing, China
Zhonggao Gao: Department of Pharmaceutics, Institute of Materia Medica, Beijing, China
Chitosan(CS) received more attention as small interfering RNA(siRNA )delivery carrier because of its low toxicity and biodegradable, however, extensive application of chitosan in gene therapy was limited due to its low transfection efficiency.
AimsTo prepare siRNA delivery carrier with high transfection efficiency.
Methods The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.